Byung-Ki Cho
Director Ejecutivo en BIONOTE, INC. .
Fortuna: 1 M $ al 30/04/2024
Perfil
Byung-Ki Cho is currently the Chief Executive Officer & Director at BioNote, Inc. He previously worked as the Director & Head-Research Center at Abbott Diagnostics Korea, Inc.
Participaciones conocidas en empresas públicas
Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
---|---|---|---|---|
SD BIOSENSOR, INC.
0.12% | 28/03/2024 | 150 000 ( 0.12% ) | 1 M $ | 30/04/2024 |
Cargos activos de Byung-Ki Cho
Empresas | Cargo | Inicio |
---|---|---|
BIONOTE, INC. | Director Ejecutivo | 01/08/2020 |
Antiguos cargos conocidos de Byung-Ki Cho.
Empresas | Cargo | Fin |
---|---|---|
Abbott Diagnostics Korea, Inc.
Abbott Diagnostics Korea, Inc. Medical SpecialtiesHealth Technology Abbott Diagnostics Korea, Inc. develops diagnostic systems for the detection of infectious diseases. Its products include rapid test kits, human immunodeficiency virus rapid test kits, blood glucose test kits, urine test kits, dengue and rapid dengue test kits, malaria rapid test kits and various forms of enzyme-linked immunosorbent assay kits. The company was founded on February 1, 1999 and is headquartered in Yongin, South Korea. | Director Ejecutivo | - |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
BIONOTE, INC. | Health Technology |
Empresas privadas | 1 |
---|---|
Abbott Diagnostics Korea, Inc.
Abbott Diagnostics Korea, Inc. Medical SpecialtiesHealth Technology Abbott Diagnostics Korea, Inc. develops diagnostic systems for the detection of infectious diseases. Its products include rapid test kits, human immunodeficiency virus rapid test kits, blood glucose test kits, urine test kits, dengue and rapid dengue test kits, malaria rapid test kits and various forms of enzyme-linked immunosorbent assay kits. The company was founded on February 1, 1999 and is headquartered in Yongin, South Korea. | Health Technology |
- Bolsa de valores
- Insiders
- Byung-Ki Cho